Myant, a leader in AI-driven healthcare solutions, has unveiled Myant Care360, an innovative service offering precision cardiac assessments directly to patients and physicians. Initially providing 14-day or longer cardiac monitoring, Care360 ensures rapid nationwide delivery of assessment devices to patients’ homes within 24-48 hours. This service facilitates both patient self-referrals and physician-initiated evaluations, streamlining access to specialized cardiac care.
Also Read: Immuta Launches AI-Driven Tools to Revolutionize Data Governance
Dr. Yaariv Khaykin, Chief Medical Officer of Myant, emphasized the importance of early detection, stating, “Atrial Fibrillation leads to impaired quality of life and affects productivity, yet many patients don’t even realize they have it.” By integrating advanced sensors and AI analytics, Care360 enables continuous ECG monitoring to detect early signs of cardiac conditions, promoting timely interventions. This approach not only enhances patient outcomes but also alleviates pressures on healthcare systems by facilitating early diagnosis and treatment. Myant’s commitment to embedding health monitoring into daily life through textile computing technologies positions Care360 as a significant advancement in accessible cardiac care.
